Noncompliance with antihypertensive medication remains an obstacle to the management of hypertension, and despite research efforts over the past decade, the predictors of noncompliance remain unclear. According to values expectancy theory, individuals rationally choose noncompliance when the barriers or costs of treatment outweigh the expected benefits. Noncompliance, therefore, is likely to occur when net costs of treatment are high.
Get full access to this article
View all access options for this article.
References
1.
Schwartz GL: Initial therapy for hypertension-individualizing care. Mayo Clin Proc65:73-78, 1990.
2.
Stason WB: Economics in hypertension management: Cost and quality trade-offs . J Hyperten5:S55-59, 1987 (Suppl. 1).
3.
National Heart Lung and Blood Institute: Hypertension prevalence and the status of awareness, treatment, and control in the United States: Final report of the subcommittee on definition and prevalence of the 1984 joint national committee. Hypertension8:457-468, 1985.
4.
Dawber TR: The Framingham Study: The Epidemiology of Atherosclerotic Disease . Cambridge, MA, Harvard University Press, 1980.
5.
Dunbar-Jacob J., Dwyer K., Dunning EJ: Compliance with antihypertension regimen: A review of the research in the 1980's. Ann Behav Med13:31-39, 1991.
6.
Juncos LI: Patient compliance and angiotension converting enzyme inhibitors in hypertension . J Cardiovasc Pharmacol15:S22-25, 1990 (Suppl. 3).
7.
Winickoff RN , Murphy PK: The persistent problem of poor blood pressure control. Arch Intern Med147:1393-96, 1987.
8.
The 1988 Joint National Committee on Detection, Evaluation, and Treatment of High Blood Pressure. Arch Intern Med148:1023-1038, 1988.
9.
Rosenstock IM: The health belief model: Explaining health behavior through expectancies , in Glanz K, Lewis FM, Rimer BK (eds.): Health Behavior and Health Education: Theory Research and Practice. San Francisco, CA, Jossey-Bass, 1990.
10.
Kaplan RM, Simon HJ: Compliance in medical care: Reconsideration of self-predictions. Ann Behav Med12:66-71, 1991.
11.
Tschann JM, Adamson TE, Coates TJ, Gullion DS: Behaviors of treated hypertensive patients and patient demographic characteristics . J Community Health13:19-32, 1988.
12.
Weingarten MA, Bannon BS: Age as a major factor affecting adherence to medication for hypertension in a general practice population . Fam Pract5:294-296, 1988.
13.
Norman SA, Marconi KM, Schezel GW, Schechter CF, Stolley PD: Beliefs, social normative influences, and compliance with antihypertensive medication. Am J Prev Med1:10-17, 1985.
14.
Klein LE: Compliance and blood pressure control. Hypertension (3 pt 2):II61-64, 1988.
15.
Ghali JK, Kadakia S., Cooper R., Ferlinz J.: Precipitating factors leading to decompensation of heart failure: Traits among urban blacks. Arch Intern Med148:2013-2016, 1988.
16.
Morse GD, Douglas JB, Upton JH, Rodgers S., Gal P.: Effect of pharmacist intervention on control of resistant hypertension. Am J Hosp Pharm43:905-909, 1986.
17.
Kirscht JP, Rosenstock IM: Patient adherence to antihypertensive medical regimens. J Community Health3:115-124, 1977.
18.
Stanton AL: Determinants of adherence to medical regimens by hypertensive patients . J Behav Med10:377-394, 1987.
19.
Trevino DB, Young EG, Groff J., Jono RT: The association between marital adjustment and compliance with antihypertension regimens. J Am Board Fam Pract1:17-25, 1990.
20.
German PS: Compliance and chronic disease. Hypertension (3pt 2):II56-60, 1988.
21.
Kirscht JP, Kirscht JL, Rosenstock IM: A test of interventions to increase adherence to hypertensive medical regimens . Health Educ Q8:261-272, 1981.
22.
Kerr Jac: Adherence and self-care. Heart Lung14:24-30, 1985.
23.
Hussey LC, Gilliland K.: Compliance, low literacy, and locus of control. Nurs Clin North Am24:605-611, 1989.
24.
Hershey JC, Morton BG, Davis JB, Reichgott MJ: Patient compliance with antihypertensive medication. Am J Public Health70:1081-1089, 1980 .
25.
Carter WB: Health behavior as a rational process: Theory of reasoned action and multiattribution utility theory, in Glanz K, Lewis FM, Rimer BK (eds.), Health Behavior and Health Education: Theory Research and Practice . San Francisco, CA, Jossey-Bass , 1990.
26.
Becker MH, Maiman LA: Social behavioral determinants of compliance with health and medical care recommendations. Med Care13:10-24, 1975.
27.
Nelson EC, Stason WB, Neutra RR, Solomon HS, McArdle PJ: The impact of patient perceptions on compliance with treatment of hypertension . Med Care16:893-906, 1987.
28.
Wallston KA , Wallston BS: Development of the Multidimensional Health Locus of Control (MHLC) scales. Health Educ Monogr6:160-167, 1978.
29.
Wallson KA, Wallston BS: Who is responsible for your health? The construct of health locus of control , in Sanders G, Suls J (eds.): Social Psychology of Health and Illness. Hillsdale, NJ; Lawrence Erlbaum, 1982.
30.
Lewis FM, Morisky DE, Flynn BS: A test of the construct validity of health locus of control: Effects on self-reported compliance for hypertensive patients. Health Educ Monogr6:138-148, 1979.
31.
Janz NK, Becker MH: The health belief model: A decade later. Health Educ Q11:1-47, 1984.
32.
Morisky DE, Green LW, Levine DM: Concurrent and predictive validity of a self-reported measure of medication adherence. Med Care74:67-74, 1986.
33.
Nelson EC, Stason WB, Neutra RR, Solomon HS: Identification of the noncompliant hypertensive patient. Prev Med9:504-517, 1980.
34.
Cummings KM , Jette AM, Rosenstock IM: Construct validation of the Health Belief Model. Health Educ Mongr6:394-405, 1978.
35.
Drug Evaluations Annual. Milwaukee, WI: American Medical Association, 1991.
36.
Morisky DE, Levine DM, Green LW, Russel RP, Smith C., Benson P., Finlay J.: The relative impact of health education for low- and high-risk patients with hypertension. Prev Med9:550-558, 1980.
37.
Haynes RB, Taylor DW, Sackett DL: Can simple clinical measurement detect patient noncompliance?Hypertension2:759-782, 1980.
38.
Fleece L., Summers MA, Schnaper H., Wilken Lo Jr, Yang S., Bradley EA: Adherence to pharmacotherapeutic regimen: Assessment and intervention . Ala J Med Sci25:389-393, 1988.
39.
Mantel N., Haenszel W.: Statistical aspects of the analysis of data from retrospective studies of disease. J Natl Cancer Inst22:719-748, 1959.
40.
Cole P., MacMahon B: Attributable risk percent in case control studies. Br J Soc Prev Med25:242-244, 1971.
41.
National High Blood Pressure Education Program (NHBPEP) and National Cholesterol Education Program (NCEP): Working Group Report on Management of Patients with Hypertension and High Blood Cholesterol . U.S. Dept. of Health and Human Services. NIH Publication. No. 90-2361, 1990.
42.
Horan MJ, Rocella EJ: Nonpharmacologic treatment of hypertension: Does it work?Eur Heart J8:77-86, 1987 (Suppl. B).
43.
Williams GH: Quality of life and its impact on hypertensive patients. Am J Med82:98-105, 1987.
44.
Kaplan NM: Antihypertensive drugs: How different classes can impact patients' coronary heart disease risk profile and quality of life. Am J Med82:9-14, 1987 (Suppl. 1A).
45.
Green LW, Levine DM, Deeds S.: Clinical trials of health education for hypertensive outpatients: Design and baseline data. Prev Med4:417-425, 1975.
46.
Webb PA: Effectiveness of patient education and psychosocial counseling in promoting compliance and control among hypertensive patients. J Fam Pract10:1047-1055, 1980.
47.
Grimm RH, Flack JM: Management of hypertension. Potential trade-offs on coronary risk. Am J Med87:62S-65S, 1989.
48.
Taylor SE, Clark LF: Does information improve adjustment to noxious events? In Sas MJ, Saxe L (eds.), Advances in Applied Social Psychology (Vol. 3). Hillsdale, NJ; Erlbaum, 1986.
49.
Ruffalo RL, Garabedian-Ruffalo SM, Garrett BN: A rational therapeutic approach to the treatment of essential hypertension: Part II. Cardiovasc Rev Reports7:818-823, 1986.
50.
Beckman HB, Frankel RM: The effect of physicians behavior on the collection of data. Ann Intern Med101:692-696, 1984.
